CHM.CN Stock Surges 900% on CNQ: Waverunner Capital Explosive May 2026

CHM.CN stock has delivered a stunning 900% gain in recent trading, catapulting Waverunner Capital Inc. into the spotlight on the CNQ exchange. The venture capital firm, based in North Vancouver, now trades at C$0.05 per share with a market cap of C$37.2 million. This explosive move marks a dramatic reversal from the stock’s previous close of C$0.005. Waverunner Capital specializes in early-stage investments, PIPEs, and bridge financing across Europe and North America. The company recently rebranded from Chemistree Technology Inc. in June 2024. Investors tracking CHM.CN stock should understand the volatility and fundamentals driving this extreme price action.

CHM.CN Stock Price Action and Market Sentiment

The 900% surge in CHM.CN stock represents one of the most dramatic single-day moves on the CNQ exchange. The stock jumped from C$0.005 to C$0.05, reflecting massive buying pressure and retail interest. Trading volume remains thin relative to the price movement, with average daily volume around 28,908 shares. The stock’s 50-day moving average sits at C$0.0424, while the 200-day average is C$0.0481, indicating the current price trades above both key technical levels.

Trading Activity and Liquidation Dynamics: The extreme volatility suggests speculative positioning rather than fundamental business improvements. Short-term traders may be capitalizing on the momentum, while longer-term investors should exercise caution. The stock’s year-to-date performance and recent rebranding have attracted attention from penny stock traders seeking high-risk, high-reward opportunities.

Waverunner Capital’s Business Model and Investment Strategy

Waverunner Capital Inc. operates as a venture capital firm focused on early-stage and seed-stage investments. The company targets equity investments between C$500,000 and C$1 million, with enterprise values ranging from C$2 million to C$5 million. The firm invests across multiple sectors including renewable energy (wind and solar), plant-based wellness, and consumer-targeted biotechnology. CEO Karl Eric Kottmeier leads the organization, which was founded in 2008 and went public in 2009.

Investment Geography and Portfolio Focus: Waverunner Capital seeks opportunities in both Europe and North America, providing geographic diversification. The company makes investments through its own balance sheet and personal capital, aligning management interests with shareholders. Track CHM.CN on Meyka for real-time updates on portfolio developments and capital deployment announcements.

Financial Metrics and Valuation Concerns

CHM.CN stock’s financial picture reveals significant challenges beneath the surface. The company reports negative earnings per share of -C$0.01 and a negative PE ratio of -5.0, indicating ongoing losses. Net income per share stands at -C$0.0595, while operating cash flow per share is -C$0.0045. The current ratio of 0.097 signals potential liquidity stress, as current liabilities exceed current assets substantially. Book value per share is negative at -C$0.1422, suggesting shareholders’ equity is underwater.

Profitability and Cash Flow Analysis: The company generated zero revenue per share in the trailing twelve months, raising questions about operational activity. Free cash flow per share mirrors operating cash flow at -C$0.0045, indicating the firm is burning cash. Return on assets stands at -0.94, while return on equity is 0.47, reflecting the challenging financial position. These metrics suggest CHM.CN stock’s price surge is driven by speculation rather than improving fundamentals.

Meyka AI Grade and Investment Outlook

Meyka AI rates CHM.CN with a grade of B and a HOLD suggestion, with a total score of 61.41 out of 100. This grade factors in S&P 500 benchmark comparison (11%), sector performance (16%), industry comparison (16%), financial growth (12%), key metrics (16%), forecasts (8%), analyst consensus (14%), and fundamental growth (7%). The HOLD rating reflects mixed signals: while the venture capital model has merit, the negative financials and thin trading liquidity present material risks.

Grade Interpretation and Caveats: The B grade indicates moderate quality relative to peers, but investors should note these grades are not guaranteed and Meyka AI is not a financial advisor. The company’s recent rebranding and strategic shift toward venture capital investing may eventually improve fundamentals, but near-term profitability remains uncertain. The extreme price volatility observed in CHM.CN stock suggests market inefficiency rather than fundamental value discovery.

Final Thoughts

CHM.CN’s 900% surge to C$0.05 reflects speculation rather than fundamental improvement. Waverunner Capital operates a legitimate venture capital business but remains unprofitable with weak cash flow and liquidity. The extreme volatility and thin trading volume indicate high risk typical of penny stocks. Meyka AI rates it HOLD with a B grade, acknowledging potential alongside material risks. Investors must conduct thorough due diligence and avoid chasing momentum. Success depends on the company’s ability to deploy capital effectively and generate returns.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.